Original Research ARTICLE
Association Between Fatigue and Motor Exertion in Patients With Multiple Sclerosis—a Prospective Study
- 1NeuroCure Clinical Research Center, Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany
- 2Department of Neurology, Park Clinic Weissensee, Berlin, Germany
- 3Department of Neurology and Experimental Neurology, Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 4Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany
- 5Department of Neurology, University of California, Irvine, Irvine, CA, United States
Background: Fatigue in multiple sclerosis (MS) is conceived as a multidimensional construct.
Objectives: This study aims to describe the changes of balance and gait parameters after 6 min of walking (6 MW) as potential quantitative markers for perceptions of state fatigue and trait fatigue in MS.
Methods: A total of 19 patients with MS (17 with fatigue) and 24 healthy subjects underwent static posturography, gait analysis, and ratings of perceived exertion before and after 6 MW.
Results: 6 MW was perceived as exhaustive, but both groups featured more dynamic comfortable speed walking after 6 MW. Shorter stride length at maximum speed and increased postural sway after 6 MW indicated fatigability of balance and gait in MS group only. While most changes were related to higher levels of perceived exertion after 6 MW (state fatigue), higher fatigue ratings (trait fatigue) were only associated with less increase in arm swing at comfortable speed. Further analysis revealed different associations of trait fatigue and performance fatigability with disability and motor functions. Performance fatigability was most closely related to the Expanded Disability Status Scale, while for trait fatigue, the strongest correlations were seen with balance function and handgrip strength.
Conclusions: Fatigability of performance was closely related to perceptions of exertion after 6 MW (state fatigue) and disability in MS but distinct from fatigue ratings, conceived as trait fatigue. Our study identified postural sway, arm swing during gait, and hand grip strength as unexpected potential motor indicators of fatigue ratings in MS.
Fatigue is a frequent and burdensome complaint even in the early disease stages of multiple sclerosis (MS) (1, 2), and there is a need for more effective treatment options (3). Although fatigue has been related to disability status, depressive symptoms, and brain connectivity in MS, there is no consensus on its etiology and the definitions of the constructs are still evolving (4, 5).
The term “fatigue” is used in different ways, ranging from unspecific (6) to more specific definitions, e.g., by the MS research council as “a subjective lack of physical and/or mental energy that is perceived by the individual or caregiver to interfere with usual and desired activities” (7). It is generally held that a sensation of fatigue does occur physiologically following an effort-demanding activity, while in the context of disease, fatigue may present as “pathological exhaustion” that occurs earlier, with lighter activity and more persistence or even independent of effort demands (8). Kluger et al. (9) proposed “perception of fatigue” and “performance fatigability” as discernible but related components of fatigue which both can present in the motor or the cognitive domain.
At the perceptional level, transient sensations of weariness or lack of energy during or right after exercise (perception of exertion) can be conceived as “state fatigue” (10), while pathological fatigue refers to a frequent, prolonged, or constant sensation over longer time frames which has been conceptualized as “trait fatigue” (11) and represents the construct assessed by the fatigue self-rating scales commonly used in MS (12, 13).
Performance fatigability as such is a physiological phenomenon. It can be described as a decline in performance with sustained activity and may be objectively quantified as the change of an appropriate performance parameter with prolonged exercise. Various performance measures and exertion paradigms have been explored for this purpose, but recent reviews concluded that there is currently no gold standard to assess fatigability in MS (14). As per one hypothesis, it has been suggested that fatigue as a symptom in MS may arise of altered interactions between perceptions of fatigue and fatigability and the relations of both to limitations in patients' functions, specifically mobility, need further study (11).
Table 1 sums up the fatigue taxonomy as used throughout this manuscript.
Given the high relevance of fatigue in MS and the ongoing efforts to find effective interventions (15), we aimed to evaluate the suitability of quantitative motor markers as measures of different components of MS fatigue. Specifically, in a first step, we described the extent of fatigability or the changes in motor parameters induced by participation in a 6-min walk test for groups of PwMS and healthy subjects. In a second step, the motor parameters indicating significant exertion effects across all participants or parameters varying between both groups with the regard to the exertion induced were related to perceived state fatigue and trait fatigue in PwMS. Additionally, these factors were also related to the patients' disability and specific motor functions.
This prospective observational study was conducted at a university MS referral center. We included people with MS (PwMS), according to the 2017 revised criteria (16), who felt able to walk independently for 6 min (6 MW), including the use of unilateral walking aids, and healthy subjects (HC) of comparable age, gender ratio, and height (Table 2).
Exclusion criteria were relapse within the last 30 days, comorbid neurological diagnosis, or any other condition with potential impact on movement functions.
The study was approved by the local institutional review board (EA1/339/16, amendment 1) and conducted in accordance with the Declaration of Helsinki in its currently applicable version. All the participants provided written informed consent.
Severity of fatigue was assessed with the 20-item Fatigue Scale for Motor and Cognitive Functions questionnaire (FSMC) (13) classified as no fatigue (<43), moderate fatigue (43–62), and most severe fatigue (>62). The sub-scores of the FSMC motor and cognitive domain were reported in the tables, but statistical tests only applied to FSMC total, as recommended previously (17).
We screened for clinically relevant depressive syndrome by using a self-reported patient health questionnaire 9 item (PHQ-9), using algorithmic classification into none, other, or major depressive syndrome (18).
Disability in PwMS was rated with the expanded disability status scale (EDSS). We recorded three indicators of motor functions:
- postural sway in static posturography (closed stance with the eyes closed) as a relevant measure of balance function (19) recorded by visual perceptive computing using Microsoft Kinect™ and a custom-written software (version 2.0.1, Motognosis GmbH, Germany) (20),
- 6 MW distance as indicator of walking endurance with known validity against habitual walking performance in MS (21), and
- hand grip strength (dominant and non-dominant hand) as a non-locomotor indicator of general functional status and physical health (22), reported as the mean of three trials for each hand according to the Southampton protocol (23) (Jamar dynamometer; Patterson Medical, USA).
Motor Fatiguing Paradigm
Figure 1 depicts the test sequence of our paradigm. After general clinical and motor assessment, 6 MW was used as a moderate-intensity exercise expected to induce performance fatigability.
To verify the level of exertion induced by 6 MW, we documented the participants' ratings of perceived exertion [BORG, score range 6 (low) to 20 (high exertion)] (24) before 6 MW and again directly after 6 MW.
To quantify the fatigability of motor performance, the participants had balance and gait assessments before and immediately after 6 MW. Fatigability was then described as difference to the baseline. Posturography was assessed in closed stance with the eyes open, then followed with the eyes closed for 20 s each as described above. Gait was recorded with Mobility Lab™ (APDM Inc., USA) from 2 × 15-m level walks with U-turn around a cone. The subjects were instructed to walk at their comfortable speed and at their maximum walking speed two times each.
Data Management and Pre-processing
One single item missing in FSMC was replaced by the mean of the remaining items of that subject. Missing items in motor parameters were considered per item and are reported with results.
Two patients performed 6 MW using a cane and one of them stopped performing the 6 MW early (4 min 25 s). These data points were included in the analysis but are indicated in the respective figures.
Data for posturography were missing for three PwMS who were unable to stand in closed stance. Two other PwMS were unable to perform closed stance with their eyes closed. Data from gait recordings were not available in one patient, and the arm and trunk parameters were missing in another four PwMS due to recording errors.
Sway during posturography was described as three-dimensional angular velocity of a vector movement of hip level mid-point relative to feet midpoint (20).
Gait parameters were calculated by the manufacturer's (APDM Inc., USA) algorithm for the plugin “Iwalk” (version 2.0) which provides algorithmic exclusion of the first steps of each walk and algorithmic definition of steps in turn. All trials were inspected for correct excision of turns (25). We additionally excluded the last stride of each trial and used only recordings with a minimum of six gait cycles. The mean of two repetitions was used for analysis. Table 3 gives an overview of all the motor parameters acquired in the fatiguing paradigm.
The descriptive analyses included a calculation of group means and standard deviations (SD) (median/interquartile range for EDSS). Normality testing was performed for all parameters using the Shapiro–Wilk test and the statistical tests were chosen accordingly (see Table 2). All gait and balance parameters (see Table 3) were normally distributed by test and inspection of plots.
Between-group comparisons for demographic and clinical characteristics used t-test, Mann–Whitney U test, or chi-square test as indicated (Table 2).
The amount of change induced by 6 MW was described as raw difference (measure-post– measure-pre = delta-measure). A positive delta thus denoted a numerical increase after exertion. Measures pre-post were compared by t-test.
We applied ANOVA for repeated measures (type III) for each motor parameter with test repetition after 6 MW (effect of exertion), status of PwMS or HC (effect of group), and interaction (effect of exertion × group) as factors.
For motor parameters with significant exertion or interaction effect, we applied Spearman correlations within the PwMS group between fatigability (delta-measure) and perceptional ratings of state (BORG post) and trait (FSMC) fatigue.
In another step of the analyses, we used correlation analysis to explore the hypothesized triangular relation between (1) perceptions of state/trait fatigue, (2) performance fatigability, and (3) MS disability and limitations in motor functions (walking function, balance, and hand grip strength).
Significance was set at p < 0.05, but trends were reported for further analysis. The statistical analyses were performed with R version 3.5.1.
FSMC indicated relevant trait fatigue in all but two of the 19 PwMS included, with more than half classified as severe fatigue. Depression screening indicated relevant depressive symptoms in four subjects. PwMS were impaired in balance and walking function, while their hand grip strength did not clearly differ from HC (Table 2).
Validity of Fatiguing Paradigm
The 6 MW, despite different individual distances walked, induced a perception of exertion in all participants, confirming validity as a motor fatiguing paradigm. We observed a three-point increase in BORG ratings after 6 MW in both groups (p < 0.001 PwMS, p < 0.001 HC; Table 2, Figure 2A), although perceived exertion in PwMS was generally higher than in HC even before 6 MW performance (Table 4).
Figure 2. Scatter plots of ratings/performance before (pre) and after (post) exertion by 6 MW for (A) Borg ratings of perceived exertion, (B) comfortable gait speed, (C) arm swing in comfortable speed walking, (D) maximum gait speed, and (E) sway in static posturography in closed stance with the eyes open. Points on the line would represent the identical pre- and post-ratings (no change), while values above this line denote the numerical increase of the respective parameter. The groups are color-coded as PwMS (orange) and HC (blue). Two patients who walked with a cane are highlighted with a black curl.
Table 4. Differences within-group for people with multiple sclerosis (PwMS) and healthy subjects (HC) between balance and gait parameters taken before (pre) and after (post) exertion by 6-min walk.
Motor Performance After Exertion
The balance and gait parameters recorded before and after 6 MW revealed a complex pattern of changes (Table 4). Worsening of balance, i.e., increase of postural sway (eyes open), was observed in PwMS only, not in HC (Figure 2E).
Concerning gait, a decline of performance in PwMS was only observed at maximum speed walking. Stride length decreased in PwMS only but remained stable in HC (Figure 2D). However, arm swing and trunk roll movements indicated larger ranges of upper body movement after 6 MW in both groups.
At comfortable speed walking, our observations clearly contrasted the expected decline of motor performance with exertion. The observed changes instead indicated a more dynamic walking pattern after 6 MW in both groups, although less pronounced in PwMS. Specifically, 6 MW induced an increase of comfortable gait speed and related parameters (cadence, stride time, and stride length) as well as increased arm and trunk motion. ANOVA revealed an interaction of the effect of exertion and group for several parameters (Table 5). Furthermore, an inspection of the respective plots suggested that the amount of change induced by 6 MW was dependent on the baseline value (Figures 2B–E). For example, Figure 2C indicates that lower arm swing velocity at baseline—occurring in PwMS with higher disability grades as well as in two elderly HC—coincides with less increase after 6 MW.
Table 5. Results of ANOVA with each gait and balance parameter as dependent variable and effect of exertion, group, and interaction as factors.
Relation of Performance Fatigability to Trait Fatigue and State Fatigue in Multiple Sclerosis
Next, we analyzed whether performance fatigability, i.e., delta induced by 6 MW, was associated with perception of state fatigue (BORG) or trait fatigue (FSMC) in MS (Table 6). Concerning state fatigue, those with higher ratings of perceived exertion after 6 MW featured less increase in speed, stride length, and arm movements at comfortable speed walking.
Table 6. Spearman correlations within PwMS group between changes in balance and gait parameters after 6 MW (delta parameter) to perception of fatigue (trait), perception of exertion, disability, and motor functions reported as rho (ρ).
Those with higher trait fatigue featured less increase of arm movements at comfortable speed walking, while no significant correlation was seen for the delta of any other balance or gait parameter. Furthermore, the subjects' ratings of state fatigue (BORG after 6 MW) were only weakly related to their ratings of trait fatigue (FSMC) (r = 0.396, p = 0.09).
Relation of Performance Fatigability, State Fatigue, and Trait Fatigue to Disability or Limitations of Motor Functions in Multiple Sclerosis
Performance fatigability—specifically delta of arm range of motion at comfortable speed walking—and state fatigue after 6 MW, were very similarly related to EDSS (r = −0.73 and 0.77), walking endurance (r = 0.77 and −0.71), and balance function (r = −0.72 and 0.59). In addition, delta of arm movement was related to grip strength in the non-dominant hand and delta of postural sway (eyes open) after 6 MW was related to baseline balance function (r = 0.61).
In contrast, the FSMC ratings, i.e., levels of trait fatigue, were rather unrelated to EDSS (r = 0.34, p = 0.13) or walking endurance (r = −0.39, p = 0.1) but showed correlations to balance function (r = 0.68) and hand grip strength (r = −0.57 for non-dominant hand) (Table 6). An inspection of the respective data plots (Figures 3A–C) revealed that the subjects with motor functions outside the normal range consistently featured relevant trait fatigue but not vice versa.
Figure 3. Correlations of the Fatigue Scale for Motor and Cognitive Functions questionnaire ratings of fatigue trait with specific motor function in multiple sclerosis: (A) walking function (6MW distance), (B) handgrip strength of the non-dominant hand, and (C) balance function (EC 3D speed). For interpretation, the means and the range of one standard deviation (solid and dashed lines) of HC are inserted.
We here report on changes of balance and gait functions after fatiguing exercise and their relation to perceptions of fatigue as well as disability and motor function in MS. In extension to many other studies, we aimed to separate fatigue as a trait variable conceived as the underlying construct of commonly used fatigue rating scales and as a state variable conceived as the actual perception of exertion induced by our 6 MW fatiguing paradigm. Our sample of PwMS featured high trait fatigue according to FSMC and low to moderate disability according to EDSS as reflected in limited walking endurance and balance function when contrasted to HC.
First, we were able to confirm that 6 MW is a fatiguing paradigm as perceptions of exertion increased after 6 MW. That the amount of change was similar in both groups despite different distances walked can be interpreted as an interaction of perceptions of (state) fatigue and fatigability, which leads to corresponding adjustments of performance (11).
Despite this, the changes observed for gait parameters when assessed before and immediately after 6 MW cannot be straightforwardly interpreted as expression of fatigability. The changes instead indicate a more dynamic gait pattern at comfortable speed walking after 6 MW in both groups with increased speed and larger arm swing and trunk movements. This observation was unexpected and, to our knowledge, this has not been described previously. This effect may combine a carry-over effect [which has been reported in other contexts (26)] from prior walking in fast pace for 6 min on the one hand and, on the other, an artifact of instructed short distance recording which may not reflect the walking speed an individual would usually assume for longer distances. In fact, 6 MW was shown to have higher validity against daily walking functions in MS compared to short-term recordings (27). The correlations of observed changes in comfortable speed walking with the level of state fatigue after 6 MW and 6 MW distance itself indicate that a “lower amount of increase” in gait parameters can be understood as expression of fatigability with delta of arm swing as the most relevant marker in this respect. Arm swing behavior is generally understudied (28) and we are not aware of its description in MS, which makes this marker difficult to interpret. As arm swing may influence recovery after tripping and improve gait efficiency and stability (28), further exploration of the arm swing behavior and the determinants in MS is highly relevant. Interestingly, in this study, arm swing also increased with exertion at maximum speed walking despite a decrease in stride length and gait speed observed in PwMS. The latter effect was not strong enough to consider it as a promising marker of performance fatigability in MS but is consistent with a decrease in walking speed reported from continuous or minute-by-minute 6 MW recordings (29, 30). As a limitation of our study, such recordings were not applied and thus respective deceleration indices could not be calculated for direct comparison. Taken together, the standardized short assessment battery of gait function applied in an appropriate fatiguing paradigm did not yield clinically applicable markers of fatigability.
The decline in balance function with exertion confirms previous reports (31). Future studies need to explore the relevance of this finding for fall risk and walking capabilities in MS. Worsening of balance with exertion has also been seen in elderly HC with prompt recovery after minutes (32) and has also been proposed for screening of workplace fatigue (33). The high susceptibility of balance function to effects of exertion surely warrants consideration in assessment protocols for balance testing. However, a more direct link of perceived fatigue to vestibular functions has been the topic of recent investigations (34), while the associations of balance function and psychological factors are largely unexplored. Of note is that the posturography system used in our study as a low-cost tool may be of potential utility for such research.
Performance fatigability, i.e., parameters' delta with exertion, was similarly correlated to BORG ratings after 6 MW and 6 MW distance, which both also had similar and robust correlations with disability and limitations of gait and balance function in MS. This is in line with previous evidence (30). It suggests that patient ratings of state fatigue after standard exercise as well as actual performance in the endurance task may both serve as good proxies for fatigability in MS. It further implies that (motor) fatigability in MS can be considered as a phenomenon closely related to the motor symptoms of the disease. The applicability of this finding in the cognitive domain or in other disease conditions needs further investigation.
As a general limitation, FSMC was not performed in HC and gender ratio between groups was not perfectly balanced. This may contribute to the underestimation of between-group difference due to a higher prevalence of fatigue in females at the population level. For FSMC correlations in PwMS, the sample size was small and included only two subjects without relevant fatigue (who were mainly unimpaired in all motor function tests). Nevertheless, in line with our results, the divergence of trait fatigue and disability in MS has been reported in larger cohorts with almost identical coefficients (12, 35) as well as the divergence of trait fatigue and fatigability (36). The occurrence of strong trait fatigue in the absence of other neurological symptoms or structural CNS change in chronic fatigue syndrome may be taken as another piece of evidence (37). Similar to our results, they (37) also found a relation of hand grip strength to the levels of trait fatigue, including a sample of PwMS. This further supports divergence between trait fatigue and MS-related disability as handgrip strength was unrelated to EDSS/6 MW and did not clearly differ from HC in our study. There is ample evidence for handgrip strength as an indicator of general health status with relations to morbidity and mortality (22), and it is one of the five criteria to define frailty in the elderly (in combination with comfortable walking speed, weight loss, physical activity, and perceptions of exhaustion) (38). Future studies on hand grip strength in MS should aim to further explore and consider possible confounders (e.g., gender, age, and body weight) to gain more robust findings.
With this in mind, what is measured by fatigue rating scales as a disabling symptom in MS may be conceived as only indirectly or in a large part even non-related to MS disability as assessed by EDSS. In fact, previous studies determined depressive symptoms as the only independent predictor of FSS ratings (12). Four depressive cases on our study scored high on FSMC and Borg post, but their motor performance in the 6 MW paradigm seemed not distinct and post hoc analysis excluding these cases did not change the essence of the results. Other possible determinants such as general health, comorbidity (and subsequent medications), physical fitness, and pain remain largely unexplored to date. Further exploration of medication effects was not feasible in our study due to the small sample size and the various drugs applied (see Table 1 of the Supplementary Material). Mechanistic studies suggested self-control (10) or internal effort–reward trade-offs (39) as other possibly relevant psychological factors in MS fatigue. While a relation of trait fatigue to balance function has been reported previously (40), we were also able to link fatigability/state fatigue to balance function. Such interaction may be interpreted as worse balance being the expression of MS disability (with impact on fatigability) and also being influenced by other factors that at the same time impact on the levels of trait fatigue. In this respect, the impact of psychological determinants, e.g., attentional control, affective state, or general health, on balance function deserves further exploration. In sum, the correlation results are in line with the recently proposed distinction between the effort-dependent and the effort-independent components of MS fatigue (8) that may prove more useful as a concept than the performance–perception duality proposed by Kluger et al. (9).
Our study adds important aspects to inform future studies on MS fatigue. State levels of fatigue (e.g., Borg ratings) after standard exercise or 6 MW distance may serve as indicators of fatigability/effort-dependent component of MS fatigue that can be considered close to MS disability but distinct from patient ratings of (trait) fatigue. Handgrip strength and balance warrant further exploration, including the determination of appropriate testing and normalization procedures, as possibly useful indicators of trait fatigue. Easy means of assessment and ample normative data for both measures support their clinical applicability. Arm swing during gait may be an additional feature of interest with possible cross-correlations to other yet undetermined factors.
Data Availability Statement
The dataset for this article is stored at Charité—Universitätsmedizin as patient consent did not include the publication of individual data.
Ethical approval was obtained by the Ethics Committee of Charité—University Hospitals Berlin. The study was conducted in accordance to the Declaration of Helsinki in its currently applicable version and to the applicable German laws. Written informed consent was approved by all participants.
AB, DD, FP, JB-S, LR, MW, and TS-H contributed to the conception and design of the study. DD, DK, JB-S, LR, PA, and TS-H contributed to the acquisition and preprocessing of data. DD and TS-H performed the statistical analysis and drafted the first version of the manuscript. All authors reviewed the manuscript for intellectual content.
This project received funding from the Deutsche Forschungsgemeinschaft (KFO Tiefe Hirnstimulation and Excellence Cluster NeuroCure). We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité—Universitätsmedizin Berlin.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We are grateful to all the participants of this study. We acknowledge the technical back-up for motor assessment by Karen Otte and Sebastian Mansow-Model.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2020.00208/full#supplementary-material
2. von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, et al. Treatment choices and neuropsychological symptoms of a large cohort of early MS. Neurol Neuroimmunol Neuroinflamm. (2018) 5:e446. doi: 10.1212/NXI.0000000000000446
3. Veauthier C, Hasselmann H, Gold SM, Paul F. The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA J. (2016) 7:25. doi: 10.1186/s13167-016-0073-3
4. Finke C, Schlichting J, Papazoglou S, Scheel M, Freing A, Soemmer C, et al. Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue. Mult Scler. (2015) 21:925–34. doi: 10.1177/1352458514555784
5. Jaeger S, Paul F, Scheel M, Brandt A, Heine J, Pach D, et al. Multiple sclerosis-related fatigue: altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex. Mult Scler. (2019) 25:554–64. doi: 10.1177/1352458518758911
8. Spiteri S, Hassa T, Claros-Salinas D, Dettmers C, Schoenfeld MA. Neural correlates of effort-dependent and effort-independent cognitive fatigue components in patients with multiple sclerosis. Mult Scler. (2019) 25:256–66. doi: 10.1177/1352458517743090
10. Wolff W, Schuler J, Hofstetter J, Baumann L, Wolf L, Dettmers C. Trait self-control outperforms trait fatigue in predicting MS patients' cortical and perceptual responses to an exhaustive task. Neural Plast. (2019) 2019:8527203. doi: 10.1155/2019/8527203
12. Flachenecker P, Kumpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. (2002) 8:523–6. doi: 10.1191/1352458502ms839oa
13. Penner IK, Raselli C, Stocklin M, Opwis K, Kappos L, Calabrese P. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. (2009) 15:1509–17. doi: 10.1177/1352458509348519
14. Severijns D, Zijdewind I, Dalgas U, Lamers I, Lismont C, Feys P. The assessment of motor fatigability in persons with multiple sclerosis: a systematic review. Neurorehabil Neural Repair. (2017) 31:413–31. doi: 10.1177/1545968317690831
15. Gaede G, Tiede M, Lorenz I, Brandt AU, Pfueller C, Dorr J, et al. Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue. Neurol Neuroimmunol Neuroinflamm. (2018) 5:e423. doi: 10.1212/NXI.0000000000000423
16. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. (2018) 17:162–73. doi: 10.1016/S1474-4422(17)30470-2
17. Biberacher V, Schmidt P, Selter RC, Pernpeinter V, Kowarik MC, Knier B, et al. Fatigue in multiple sclerosis: associations with clinical, MRI and CSF parameters. Mult Scler. (2018) 24:1115–25. doi: 10.1177/1352458517712078
19. Fritz NE, Newsome SD, Eloyan A, Marasigan RE, Calabresi PA, Zackowski KM. Longitudinal relationships among posturography and gait measures in multiple sclerosis. Neurology. (2015) 84:2048–56. doi: 10.1212/WNL.0000000000001580
20. Behrens JR, Mertens S, Kruger T, Grobelny A, Otte K, Mansow-Model S, et al. Validity of visual perceptive computing for static posturography in patients with multiple sclerosis. Mult Scler. (2016) 22:1596–606. doi: 10.1177/1352458515625807
22. Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum AJr, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology. (PURE) study. Lancet. (2015) 386:266–73. doi: 10.1016/S0140-6736(14)62000-6
23. Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. (2011) 40:423–9. doi: 10.1093/ageing/afr051
25. Kroneberg D, Elshehabi M, Meyer AC, Otte K, Doss S, Paul F, et al. Less is more - estimation of the number of strides required to assess gait variability in spatially confined settings. Front Aging Neurosci. (2018) 10:435. doi: 10.3389/fnagi.2018.00435
26. Schmitz-Hubsch T, Brandt AU, Pfueller C, Zange L, Seidel A, Kuhn AA, et al. Accuracy and repeatability of two methods of gait analysis - GaitRite und Mobility Lab - in subjects with cerebellar ataxia. Gait Posture. (2016) 48:194–201. doi: 10.1016/j.gaitpost.2016.05.014
27. Stellmann JP, Neuhaus A, Gotze N, Briken S, Lederer C, Schimpl M, et al. Ecological validity of walking capacity tests in multiple sclerosis. PLoS ONE. (2015) 10:e0123822. doi: 10.1371/journal.pone.0123822
29. Socie MJ, Motl RW, Sosnoff JJ. Examination of spatiotemporal gait parameters during the 6-min walk in individuals with multiple sclerosis. Int J Rehabil Res. (2014) 37:311–6. doi: 10.1097/MRR.0000000000000074
30. Leone C, Severijns D, Dolezalova V, Baert I, Dalgas U, Romberg A, et al. Prevalence of walking-related motor fatigue in persons with multiple sclerosis: decline in walking distance induced by the 6-minute walk test. Neurorehabil Neural Repair. (2016) 30:373–83. doi: 10.1177/1545968315597070
31. McLoughlin JV, Barr CJ, Crotty M, Sturnieks DL, Lord SR. Six minutes of walking leads to reduced lower limb strength and increased postural sway in people with Multiple Sclerosis. NeuroRehabilitation. (2014) 35:503–8. doi: 10.3233/NRE-141143
32. Helbostad JL, Sturnieks DL, Menant J, Delbaere K, Lord SR, Pijnappels M. Consequences of lower extremity and trunk muscle fatigue on balance and functional tasks in older people: a systematic literature review. BMC Geriatr. (2010) 10:56. doi: 10.1186/1471-2318-10-56
34. Hebert JR, Corboy JR, Vollmer T, Forster JE, Schenkman M. Efficacy of balance and eye-movement exercises for persons with multiple sclerosis (BEEMS). Neurology. (2018) 90:e797–807. doi: 10.1212/WNL.0000000000005013
35. Motl RW, Balantrapu S, Pilutti L, Dlugonski D, Suh Y, Sandroff BM, et al. Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis. Eur J Phys Rehabil Med. (2013) 49:59–66.
36. Loy BD, Taylor RL, Fling BW, Horak FB. Relationship between perceived fatigue and performance fatigability in people with multiple sclerosis: a systematic review and meta-analysis. J Psych Res. (2017) 100:1–7. doi: 10.1016/j.jpsychores.2017.06.017
38. Theou O, Cann L, Blodgett J, Wallace LM, Brothers TD, Rockwood K. Modifications to the frailty phenotype criteria: systematic review of the current literature and investigation of 262 frailty phenotypes in the Survey of Health, Ageing, and Retirement in Europe. Ageing Res Rev. (2015) 21:78–94. doi: 10.1016/j.arr.2015.04.001
39. Dobryakova E, Hulst HE, Spirou A, Chiaravalloti ND, Genova HM, Wylie GR, et al. Fronto-striatal network activation leads to less fatigue in multiple sclerosis. Mult Scler. (2018) 24:1174–82. doi: 10.1177/1352458517717087
Keywords: multiple sclerosis, fatigability, state/trait-fatigue, walking, balance
Citation: Drebinger D, Rasche L, Kroneberg D, Althoff P, Bellmann-Strobl J, Weygandt M, Paul F, Brandt AU and Schmitz-Hübsch T (2020) Association Between Fatigue and Motor Exertion in Patients With Multiple Sclerosis—a Prospective Study. Front. Neurol. 11:208. doi: 10.3389/fneur.2020.00208
Received: 09 December 2019; Accepted: 09 March 2020;
Published: 15 April 2020.
Edited by:Brian M. Sandroff, University of Alabama at Birmingham, United States
Reviewed by:Nora E. Fritz, Wayne State University, United States
Elisabeth Gulowsen Celius, Oslo University Hospital, Norway
Luca Prosperini, San Camillo-Forlanini Hospital, Italy
Copyright © 2020 Drebinger, Rasche, Kroneberg, Althoff, Bellmann-Strobl, Weygandt, Paul, Brandt and Schmitz-Hübsch. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tanja Schmitz-Hübsch, email@example.com